Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.8K
Stem Cell Culture01:17

Stem Cell Culture

6.3K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Retina-specific long non-coding RNAs associated with inherited retinal disease genes.

Cellular and molecular life sciences : CMLS·2026
Same author

Mitochondrial DNA heteroplasmy drives cortical neuronal disturbances in human organoids harbouring the common m.3243A>G mutation.

Nature communications·2026
Same author

Soft-shell phacoemulsification in Fuchs' endothelial dystrophy: Central corneal thickness as a predictor of post-operative keratoplasty.

European journal of ophthalmology·2026
Same author

Retinal organoid screening reveals ABT-737 and luminespib as potential agents against a cone- precursor-derived subtype of retinoblastoma.

Molecular therapy. Oncology·2026
Same author

Shaping the next era of stem cell science: a vision for stem cells journal and its global community.

Stem cells (Dayton, Ohio)·2025
Same author

IVCM image analysis for limbal stem cell deficiency: quantitative diagnostics of the corneal epithelium post-transplant recovery.

The ocular surface·2025

相关实验视频

Updated: Mar 11, 2026

A Simple Mechanical Procedure to Create Limbal Stem Cell Deficiency in Mouse
04:55

A Simple Mechanical Procedure to Create Limbal Stem Cell Deficiency in Mouse

Published on: November 17, 2016

8.8K

实施干细胞疗法用于肢体干细胞缺乏症.

Eldo Galo1, Francisco C Figueiredo1,2, Majlinda Lako1

  • 1Biosciences Institute, Newcastle University, Newcastle Upon Tyne, UK.

Regenerative medicine
|March 10, 2026
PubMed
概括
此摘要是机器生成的。

淋巴干细胞缺乏症 (LSCD) 治疗方法正在进步,但结果各不相同. 未来的研究重点是更好的干细胞表征和通用捐赠细胞,以提高这种具有挑战性的眼睛疾病的疗效.

关键词:
视角膜 视角膜 是一个在LSCD中,我们可以看到LSCD.这些LSCs是LSCs.细胞治疗疗法细胞治疗疗法角膜上皮质 角膜上皮质

更多相关视频

Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research
10:11

Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research

Published on: October 27, 2023

1.6K
Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells
10:07

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Published on: October 24, 2018

8.3K

相关实验视频

Last Updated: Mar 11, 2026

A Simple Mechanical Procedure to Create Limbal Stem Cell Deficiency in Mouse
04:55

A Simple Mechanical Procedure to Create Limbal Stem Cell Deficiency in Mouse

Published on: November 17, 2016

8.8K
Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research
10:11

Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research

Published on: October 27, 2023

1.6K
Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells
10:07

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Published on: October 24, 2018

8.3K

科学领域:

  • 眼科医生 眼科 眼科
  • 再生医学是一种再生医学.
  • 干细胞生物学 干细胞生物学

背景情况:

  • 淋巴干细胞缺乏症 (LSCD) 是一种严重的眼表面疾病,具有重大治疗挑战,特别是在双边病例中.
  • 目前的治疗方法已经发展了几十年,但长期的结果仍然不一致,原因是疾病严重程度和免疫排斥等因素.

研究的目的:

  • 审查目前的LSCD手术和干细胞治疗的现状.
  • 突出现有和新兴治疗的临床结果,局限性和翻译挑战.
  • 讨论未来的方向,以提高LSCD治疗的有效性和可访问性.

主要方法:

  • 审查目前的LSCD手术和干细胞干预措施.
  • 检查自主和异种肢体上皮移植,简单的肢体上皮移植,口腔粘膜衍生的方法,介质干细胞疗法和诱导多能干细胞衍生的角膜上皮.
  • 对临床结果,生物限制和转化障碍的分析.

主要成果:

  • 基于干细胞的干预已经改变了LSCD的管理,但临床结果是可变的.
  • 关键影响因素包括疾病严重程度,免疫排斥,干细胞质量和眼表面微环境优化.
  • 目前正在探索各种方法,包括移植,口腔粘膜移植,MSC和iPSC衍生的角膜上皮.

结论:

  • 改善LSCD疗法需要更好的干细胞特征和开发低免疫或通用供体细胞产品.
  • 解决生物局限性和翻译挑战对于提高治疗疗效至关重要.
  • 未来的方向旨在改善LSCD患者的可访问性和长期成功率.